Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good for $SCYX if true, but not great in general:
""
Johnson & Johnson, Sanofi, Pfizer, AstraZeneca, Novartis, Otsuka and many others have all gutted their antibiotic development teams and moved those budgets elsewhere. This is despite a 2016 pledge signed by over 100 companies, including Johnson & Johnson and Novartis, saying they would help prevent the next epidemic by investing in ways to combat the rise of antibiotic-resistant "superbugs."
""
https://www.dw.com/en/big-pharma-nixes-new-drugs-despite-impending-antibiotic-apocalypse/a-50432213
Guardion's exhibitor link: https://west.visionexpo.com/en/Exhibitors/6201670/Guardion-Health-Sciences
Anyone know what's going on with their medical isotope business? I emailed US Nuclear Corp and now waiting for a response.
From their last 10Q about patent infringement by TauroPharm, "An oral hearing has been scheduled for September 17, 2019."
It also mentions a hearing on Sept 6th. Not sure which date is final.
http://irdirect.net/filings/viewer/index/1410098/000165495419009628/
More news soon?
NCT03059992 Primary Completion Date: September 2019 https://clinicaltrials.gov/ct2/show/NCT03059992
Looks like it closed nicely. I wonder if they'll update the estimated primary and study completion dates for https://clinicaltrials.gov/ct2/show/NCT03432260.
No longer accepting applications for the Business Development VP position. Did they find someone? https://www.linkedin.com/jobs/view/1371600675/
Edible and vape retail sales starting this Dec 2019 in Canada might increase overall usage. It would be amazing if the actions taken to delay sales was, behind the scenes, related to THC detection devices being ready for piloting. Old news, but a reminder:
https://www.bloomberg.com/news/articles/2019-06-14/pot-edibles-vapes-to-hit-canadian-stores-shelves-in-december
POS? PaidEasy
Learn more about how @Cemtrex built a POS integrated one tap payment solution for retail and hospitality. #marketing #branding https://t.co/vOEeSpah6A
— Agency Spotter (@agencyspotter) August 16, 2019
Mino-Lok study NCT02901717 update posted on Aug 14th. New primary completion date is Dec 2019. New study completion date is June 2020. Study locations added/removed.
https://clinicaltrials.gov/ct2/history/NCT02901717?A=4&B=5&C=merged
Job posted 11 hours ago for Vice President / Sr. Vice President, Business Development https://www.linkedin.com/jobs/view/1371600675/
It will be an uphill battle trying to compete with just one of the giants, e.g. $ACB, $CGC, etc. Their pockets are way too deep and $ACB, for example, has acquired so many other businesses without blinking. I agree that $PHOT should focus on their cloning system and advisory services for their best chance.
Hegyi mentioned it could take ~3 - 5 years to get a US patent for their Commercial Cloning System. Not sure if this is the same design which they did get a patent for in Canada (announced 7/11), "patent number 2,985,009 by the Canadian Patent Authority on the design of its commercial cloning unit."
Marco Hegyi mentioned exciting announcements in the next 30 days and also a decision on the future of their vertical grow system, which they have Phase 3 data on. I'm guessing their vertical grow system is not what they'll continue putting money into.
He also mentioned his board is open to being acquired if the valuation is appropriate for shareholders.
NCT03837743 update posted on Aug 9th with new primary and study completion date of Oct 2019 and new sites added in Florida.
https://clinicaltrials.gov/ct2/history/NCT03837743?A=2&B=3&C=merged#StudyPageTop
Is market close on Aug 12th when $DRRX is minimum bid price compliant ($1+) on the Nasdaq Capital Market? I believe that's 10 business days since they've been $1+. Can anyone else confirm?
Update to NCT03987620 posted 8/6. Looks like they added locations and contacts. https://clinicaltrials.gov/ct2/history/NCT03987620?A=2&B=3&C=merged#StudyPageTop
https://audioboom.com/posts/7333228-us-nuclear-ceo-robert-goldstein-joins-the-stock-day-podcast-to-announce-the-company-s-uplisting
It may be a long while, but CEO has NASDAQ uplisting in mind.
10-Q expected next week
Second-quarter results expected out next week. Yesterday’s 8K announced $1 million reserve note for bridge financing only as needed. https://t.co/ZAAN47xYvp
— Marco Hegyi (@marcohegyi) July 31, 2019
Possibly one of the Tiara patents being issued on 7/30: https://bit.ly/2yr0qHn
Just guessing, maybe it wasn't newsworthy or might be included in the next PR. I think they still have a number of Tiara patents that haven't been granted or issued.
This time it was just a Twitter search (saved search) for $NWBO.
Yep, I noticed after it was too late to modify my message.
Someone "passing the 5-year milestone with GBM" today. Amazing.
Today we celebrate my Dad passing the 5-year milestone with GBM. We are thankful for the ongoing support from the CCI Edmonton and Northwest Biotherapeutics, and especially for the hours of caregiving my Mom offers every single day! Go Dad! #GBM #Glioblastoma $NWBO pic.twitter.com/PlypOApbpk
— Kristyn Power, CFA (@KristynPower) July 28, 2019
He also acknowledged Dr. Marianna Nuti in his book, The Finch in My Brain, for working on the dendritic vaccine. Just a wild guess, but maybe:
https://www.researchgate.net/profile/Marianna_Nuti
First one in 2011 was in Italy, not sure about following treatments:
Can I ask where you got the dendritic vaccine? Was it in the U.K.?
— 🖤Spencer Cookie (@crowmogh) April 1, 2019
Anyone happen to know how reputable Oil & Gas 360 is? https://www.oilandgas360.com/long-awaited-fusion-energy-breakthrough-finally-arrives/
@turning stone: No worries and I'm also invested in $DRRX for over a year now. Probably not as heavily as others, but nevertheless invested. I'm very blunt with posting, so I can see how I get misunderstood.
I don't have a medical background, but believe in companies that are trying to improve lives. I appreciate anyone who posts facts from official sources and documentation, such as clinicaltrials.gov. I obviously prefer good news, but anything to stay informed helps. If you have any information in the future, please do share.
I think there's a misunderstanding. I was unaware until someone else pointed out (elsewhere) that this was already expected and Durect just needed to update their ClinicalTrials documents. I'm bullish and was simply posting facts. I'm being objective, scaring wasn't the intention.
I sent this privately to @turning stone, but figured I should clarify to anyone else who got offended.
Sounds like this trial/program was shut down in January and mentioned in a PR, so not new info.
One of the $DRRX clinical studies was terminated. Study update was posted today 7/18:
"A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis (PSC)"
https://clinicaltrials.gov/ct2/show/record/NCT03394781
@Clariske, indeed. If you are invested, let's pray together.
"We are working daily to put the appropriate procedures in place to meet the standards and transparency required of a NASDAQ listed company. We pledge that transparency will be a major focus for us moving forward. We hope to be fully GAAP-compliant with audited financials starting in year 2020."
https://investors.medicalmarijuanainc.com/medical-marijuana-shareholder-letter/